Literature DB >> 7508353

Effects of bradykinin on [3H]-norepinephrine release in rat hypothalamus.

K Tsuda1, S Tsuda, M Goldstein, I Nishio, Y Masuyama.   

Abstract

1. We examined the regulatory actions of bradykinin on norepinephrine release in the hypothalamus of rats. 2. Bradykinin increased the stimulation-evoked [3H]-norepinephrine release from hypothalamic slices of Sprague-Dawley rats in a dose-dependent manner (1 Hz: S2/S1 ratio, mean +/- s.e.m., control 0.868 +/- 0.016, n = 6; bradykinin 1 x 10(-6) mol/L 1.039 +/- 0.018, n = 6, P < 0.05; bradykinin 3.3 x 10(-6) mol/L 1.130 +/- 0.064, n = 6, P < 0.05). The basal release of [3H]-norepinephrine was not affected by the peptide. 3. Bay K 8644, a dihydropyridine-sensitive calcium channel agonist, significantly potentiated the facilitatory effect of bradykinin on norepinephrine release, although Bay K 8644 by itself had no significant effect. By contrast, nicardipine, a dihydropyridine-sensitive calcium channel blocker, reversed the increase in norepinephrine release induced by bradykinin and Bay K 8644. 4. These results indicate that bradykinin may increase norepinephrine release in rat hypothalamus, partially mediated by interactions with dihydropyridine-sensitive calcium channels.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7508353     DOI: 10.1111/j.1440-1681.1993.tb03016.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  2 in total

1.  Modulatory effect of bradykinin on the release of noradrenaline from rat isolated atria.

Authors:  C Chulak; R Couture; S Foucart
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

2.  Endostatin inhibits bradykinin-induced cardiac contraction.

Authors:  Jumpei Yasuda; Lila Takada; Yuka Kajiwara; Muneyosi Okada; Hideyuki Yamawaki
Journal:  J Vet Med Sci       Date:  2015-06-05       Impact factor: 1.267

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.